Antiretroviral therapy in human immunodeficiency virus-infected individuals.
Spooner
K M
KM
Department of Internal Medicine, National Naval Medical Center, Bethesda, Maryland, USA.
D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D018890:Chemoprevention; D002985:Clinical Protocols; D003657:Decision Making; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D006678:HIV / Q000235:genetics / Q000254:growth & development; D015658:HIV Infections / Q000188:drug therapy* / Q000635:transmission / Q000821:virology; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D010347:Patient Care Planning; D012367:RNA, Viral / Q000032:analysis; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D019562:Viral Load; D014766:Viremia / Q000821:virology; D014779:Virus Replication / Q000187:drug effects; D015215:Zidovudine / Q000627:therapeutic use
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D012367:RNA, Viral; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine